GO
Loading...

Sanofi SA

More

  • Drug Spending Drops for the First Time in 55 Years Thursday, 9 May 2013 | 8:31 AM ET

    Patent expirations on big-name drugs has resulted in modestly less spending on medicines in the U.S. for the first time in at least 55 years, a report showed Thursday.

  • Fear on the Floor Ahead of Jobs Report Thursday, 2 May 2013 | 9:54 AM ET

    There's a lot of fear about Friday's jobs report. Bears are already saying this could be the report that finally forces the markets to take a breather.

  • Futures Gain After Jobless Claims, ECB Rate Cut Thursday, 2 May 2013 | 9:17 AM ET

    U.S. stock index futures climbed Thursday as Wall Street cheered a better-than-expected jobless claims report and after the European Central Bank cut its key interest rate.

  • Fed May Provide a Safety Net for the Market Friday, 26 Apr 2013 | 8:08 PM ET
    A trader at the Chicago Board Options Exchange (CBOE).

    The Fed is expected to repeat its dovish message in the coming week, which could provide a safety net for the market amid a big wave of earnings and the April jobs report.

  • Bird Flu Returns, but China's Better Prepared: CEO Thursday, 11 Apr 2013 | 2:11 PM ET
    Authorities in China confirmed infections caused by the H7N9 flu strain found in chicken and duck samples in eastern China.

    China is handling an outbreak of bird flu much better than in the past, Sanofi CEO Chris Viehbacher told CNBC on Thursday.

  • Sanofi CEO on Bird Flu Fears  Thursday, 11 Apr 2013 | 1:25 PM ET

    Sanofi CEO Chris Viehbacher shares his opinion on how China has handled recent bird flu concerns and what impact President Obama's budget might have on pharmaceuticals.

  • China Rolls Up Sleeves in Fight Against Bird Flu Friday, 5 Apr 2013 | 12:32 AM ET

    China said it was mobilizing resources nationwide to combat a new strain of bird flu that has killed six people, as Japan, Hong Kong and the United States stepped up vigilance.

  • Pro's Best Buys in Health Care Tuesday, 26 Mar 2013 | 1:21 PM ET

    A few health care stocks still hold potential, Orbimed Advisors Managing Partner Sam Isaly says.

  • Weak Euro can be Good for Exporters  Monday, 25 Mar 2013 | 11:05 PM ET

    Simon Grose-Hodge, Head of Investment Advisory, Singapore at LGT Bank talks Cyprus and tells CNBC's Cash which stocks will benefit from the weak euro.

  • 4 Biotech Stock Stars Losing Their Luster Thursday, 21 Feb 2013 | 12:19 PM ET

    These four biotech stocks could take a big hit when investors start to focus on lower-valued stocks in other industries. TheStreet.com reports.

  • Stocks finished slightly lower in lackluster trading Monday as investors remained cautious amid a lack of new market catalysts following the recent rally that helped the S&P 500 end its sixth-consecutive week higher.

  • Midday Movers: REGN, FOSL & More Monday, 11 Feb 2013 | 2:17 PM ET

    Take a look at some of Monday midday movers:

  • Europe Stocks Mixed, Healthcare Weighs Monday, 11 Feb 2013 | 10:52 AM ET

    European shares closed lower on Monday as sharp falls in Danish pharma group Novo Nordisk outweighed rallies in rival Sanofi and Dutch retailer Ahold.

  • Early Movers: DELL, GOOG, SNY & More Monday, 11 Feb 2013 | 8:22 AM ET

    Some of the names on the move ahead of the open.

  • U.S. regulators dealt a major blow to Novo Nordisk's hopes for its new long-acting insulin Tresiba by demanding the Danish drugmaker conduct additional clinical tests to assess potential heart risks.

  • Sanofi Leads European Shares to 2013 Closing Low Thursday, 7 Feb 2013 | 9:31 AM ET

    European shares closed lower after choppy trading on Thursday, tracking falls on the U.S. equity markets.

  • Different Approach to Innovation: Sanofi CEO  Thursday, 7 Feb 2013 | 4:20 AM ET

    Christopher Viehbacher, CEO of Sanofi, pledges a different and radical approach to innovation.

  • Pfizer's animal health subsidiary Zoetis raised $2.2 billion in its public offering on Thursday, becoming the largest IPO from a U.S. company since Facebook.

  • Denmark's Nokia Moment on $100 Billion Stock Friday, 1 Feb 2013 | 6:37 AM ET
    Copenhagen, Denmark

    Denmark is facing its "Nokia moment"; drugmaker Novo Nordisk has ballooned into a $100 billion giant, dominating its home stock market just as the Finnish firm did at the height of the 1990s tech boom.

  • Denmark Faces Nokia Moment on $100 Billion Stock Friday, 1 Feb 2013 | 5:28 AM ET

    Denmark is facing its "Nokia moment"; drugmaker Novo Nordisk has ballooned into a $100 billion giant, dominating its home stock market just as the Finnish firm did at the height of the 1990s tech boom.